Definium Therapeutics (DFTX) Amortizatization of Intangibles (2020 - 2026)
Definium Therapeutics (DFTX) reported Amortizatization of Intangibles of -$591000.0 for Q1 2026, up 74.07% on a QoQ basis from -$2.3 million in Q4 2025.
Definium Therapeutics (DFTX) has 7 years of Amortizatization of Intangibles data on file, last reported at -$591000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles changed N/A year-over-year to -$591000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$591000.0 (down 12.14% YoY) and the FY2023 annual result came in at $3.2 million, up 0.63% from the prior year.
- Amortizatization of Intangibles rose to -$591000.0 in Q1 2026 per DFTX's latest filing, from -$2.3 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.3 million in Q3 2025 and bottomed at -$2.3 million in Q4 2025.
- The 5-year median for Amortizatization of Intangibles is $800000.0 (2022), against an average of $443769.2.
- The widest annual swing landed in 2023, when Amortizatization of Intangibles advanced 2.56%; it then tumbled 332.45% in 2025.
- Tracing DFTX's Amortizatization of Intangibles over 5 years: stood at $780000.0 in 2022, then rose by 2.56% to $800000.0 in 2023, then tumbled by 165.88% to -$527000.0 in 2024, then sank by 332.45% to -$2.3 million in 2025, then soared by 74.07% to -$591000.0 in 2026.
- Per Business Quant, the three latest DFTX Amortizatization of Intangibles figures stand at -$591000.0 (Q1 2026), -$2.3 million (Q4 2025), and $2.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - | -591,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -591,000.00 |
| Mar 31, 2026 | -591,000.00 |
| Dec 31, 2025 | -2.28 Mn |
| Dec 31, 2025 | -2.28 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Sep 30, 2025 | 2.28 Mn |
| Dec 31, 2024 | -527,000.00 |
| Dec 31, 2024 | -527,000.00 |
| Mar 31, 2024 | 527,000.00 |
| Mar 31, 2024 | 527,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Sep 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Jun 30, 2023 | 800,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Dec 31, 2022 | 780,000.00 |
| Dec 31, 2022 | 780,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 800,000.00 |
| Mar 31, 2022 | 780,000.00 |
| Mar 31, 2022 | 780,000.00 |
| Dec 31, 2021 | 788,000.00 |
| Dec 31, 2021 | 788,000.00 |
| Sep 30, 2021 | 800,000.00 |
| Sep 30, 2021 | 800,000.00 |
| Jun 30, 2021 | 3.26 Mn |
| Jun 30, 2021 | 3.26 Mn |
| Mar 31, 2021 | 1.18 Mn |
| Mar 31, 2021 | 1.18 Mn |
| Dec 31, 2020 | -413,000.00 |
| Dec 31, 2020 | -413,000.00 |
| Sep 30, 2020 | 137,000.00 |
| Sep 30, 2020 | 137,000.00 |
| Jun 30, 2020 | 138,000.00 |
| Jun 30, 2020 | 138,000.00 |
| Mar 31, 2020 | 138,000.00 |
| Mar 31, 2020 | 138,000.00 |